An autopsy case of pulmonary veno-occlusive disease refractory to imatinib

Koiwa H., Tsujino I., Ikeda D., Ohira H., Tanino M., Nishimura M.

Source: Eur Respir J 2011; 37: 968-970
Journal Issue: April

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Koiwa H., Tsujino I., Ikeda D., Ohira H., Tanino M., Nishimura M.. An autopsy case of pulmonary veno-occlusive disease refractory to imatinib. Eur Respir J 2011; 37: 968-970

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis
Source: Eur Respir J 2009; 33: 517-520
Year: 2009


Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



Pulmonary veno-occlusive disease in myeloproliferative disorder
Source: Eur Respir J 2009; 33: 213-216
Year: 2009



IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment
Source: Eur Respir J 2014; 43: 1516-1519
Year: 2014


Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


The use of genetic testing in an atypical presentation of pulmonary veno-occlusive disease
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture
Source: Eur Respir J 2009; 33: 666-669
Year: 2009



Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 34: 1348-1356
Year: 2009



Rituximab in the treatment of refractory pulmonary sarcoidosis
Source: Eur Respir J 2014; 43: 1525-1528
Year: 2014


Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004


Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Source: ERJ Open Res, 5 (1) 00168-2018; 10.1183/23120541.00168-2018
Year: 2019



Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Pulmonary veno-occlusive disease
Source: Eur Respir J 2016; 47:1518-1534
Year: 2016



Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Source: Eur Respir J 2009; 33: 1498-1502
Year: 2009



Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

A case of HIV-associated multicentric Castleman disease with pulmonary involvement
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012